FMS Valuation

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

FMS Relative Valuation

FMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FMS is overvalued; if below, it's undervalued.

Historical Valuation

Fresenius Medical Care AG (FMS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 8.05 is considered Undervalued compared with the five-year average of 14.95. The fair price of Fresenius Medical Care AG (FMS) is between 37.96 to 53.27 according to relative valuation methord. Compared to the current price of 23.82 USD , Fresenius Medical Care AG is Undervalued By 37.26%.

Relative Value

Fair Zone

37.96-53.27

Current Price：23.82

37.26%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.43

P/B

Median3y

0.78

Median5y

1.12

14.22

FCF Yield

Median3y

14.24

Median5y

13.52

Competitors Valuation Multiple

The average P/S ratio for FMS's competitors is 1.22, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS) exhibits a P/S ratio of 0.59, which is -51.59% above the industry average. Given its robust revenue growth of -2.59%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

FMS.N

Fresenius Medical Care AG